Skip to content
Open access

Mitochondrial NCLX couples glucagon- and PDE2A-Dependent signals to regulate hepatic lipid metabolism

Aug 2026 · Molecular Metabolism · Vol 113, pp. 102433 · 1 citation · 97 references
Medicine

TL;DR

The glucagon–PDE2A–PKA–NCLX signaling axis is established as a key metabolic rheostat integrating mitochondrial calcium dynamics with lipid homeostasis, providing a promising therapeutic target for MASLD.

Abstract

Mitochondrial calcium signaling, particularly its glucagon-mediated oscillatory dynamics, plays a pivotal role in regulating hepatic metabolism and is known to be disrupted in steatotic liver disease. We recently identified the mitochondrial Na+/Ca2+exchanger NCLX as a key mediator of glucagon-induced mitochondrial calcium oscillations, essential for proper gluconeogenic function. Here, using hepatocyte-specific NCLX knockout (cKO) mice, we demonstrate that NCLX is critical for intrahepatic lipolysis and fatty acid oxidation (FAO); its loss impairs glucagon-stimulated lipid droplet catabolism and blunts FAO. Mechanistically, we find that NCLX deficiency disrupts allosteric activation of lipolytic enzymes and increases CPT1 sensitivity to malonyl-CoA-mediated inhibition, resulting in defective lipolysis and FAO. We further show that glucagon regulates hepatic NCLX via cAMP/PKA-dependent phosphorylation at NCLX Ser258. Notably, PDE2A acts as a negative regulator of this pathway by degrading mitochondrial cAMP. Hepatic mitochondrial PDE2A abundance and cAMP-degrading activity are elevated in HFD, and in vivo BAY 60-7550 treatment suppresses mitochondrial cAMP degradation and augments PKA signaling in steatotic livers. Pharmacologic inhibition of PDE2A with BAY 60-7550 enhances NCLX phosphorylation, restores mitochondrial calcium efflux and oscillations, and stimulates FAO in an NCLX-dependent manner. Importantly, we uncover that cAMP/PKA-dependent phosphorylation of NCLX at Ser258 is suppressed in human steatotic livers, and that pharmacologic inhibition of PDE2A ameliorates hepatic FAO and steatosis in both dietary and genetic MASLD models. Collectively, our findings establish the glucagon–PDE2A–PKA–NCLX signaling axis as a key metabolic rheostat integrating mitochondrial calcium dynamics with lipid homeostasis, providing a promising therapeutic target for MASLD.

Read PDF

Similar papers

Review Open access Oct 2026

The AMPK signaling pathway in cell metabolism and human diseases

Adenosine 5’-monophosphate−activated protein kinase (AMPK), a highly conserved energy-sensing kinase, plays a central role in maintaining cellular metabolic homeostasis, such as glucose/lipid metabolism, mitochondrial biogenesis, and autophagy, to counteract energetic stress. Beyond the canonical adenylate-dependent ac...

Zheng-Kui Zhang, Yuan-Zhuo Gu, Hong-Chao He et al. · 0 citations
Open access Sep 2026

GLP-1 Signaling, Mitochondrial Energy Regulation, and Evolutionary Conservation: From NAD⁺ Bioenergetics to Microbial Ecosystems

Glucagon-like peptide-1 (GLP-1) receptor agonists have become revolutionary therapies against metabolic dis- eases, obesity, and even neurological disorders. In addition to its role as an incretin hormone, GLP-1 is involved in modulating mitochondria energetics and the cellular redox status through direct actions. The...

George B. Stefano · 0 citations
Open access Oct 2026

Carbonic anhydrase VIII regulates IP3R1-dependent Ca2+ signaling to coordinate insulin secretion and hepatic glucose production

Intracellular Ca2+ signaling is essential for glucose-induced insulin secretion (GIIS) and hepatic glucose production (HGP), yet how Ca2+ dynamics are coordinated across organs remains unclear. Carbonic anhydrase VIII (CA8), an endogenous inhibitor of inositol 1,4,5-trisphosphate receptor 1 (IP3R1), was identified as a...

Muhammad Fauzi, Takaaki Murakami, Ryota Usui et al. · 0 citations
Open access Sep 2026

A PPARγ-like signalling axis integrates lipid homeostasis and mitochondrial quality control to preserve neuronal integrity

A PPARγ-like signalling axis that integrates sphingolipid metabolism, organelle quality control, and neuronal homeostasis is identified, providing a mechanistic framework for understanding how metabolic regulation promotes neuroprotection.

Dikaia Tsagkari, Maria Markaki, Tao Zhang et al. · 0 citations
Open access Sep 2026

ENPP1 buffers extracellular cGAMP in brown adipose tissue to limit insulin resistance.

The mechanism underlying the role of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) in metabolic disease remains unsolved. Using a 2'3'-cyclic GMP-AMP (cGAMP)-hydrolysis-deficient mouse (Enpp1H362A), we show that selective loss of this activity exacerbates high-fat diet (HFD)-induced weight gain and insulin...

Song-Nan Wang, Ying-Jie Guo, Wei-Dong An et al. · 0 citations
Review Open access Nov 2026

Beyond Thr172 phosphorylation: subunit-selective, spatial, and post-translational AMPK signaling in diabetic cardiomyopathy

AMP-activated protein kinase (AMPK) is widely examined in diabetic cardiomyopathy (DCM) through total protein abundance and activation-loop phosphorylation, typically reported as p -AMPK Thr172 . Yet these measurements cannot identify the active αβγ heterotrimer, cellular source, intracellular location, or regu...

Ye-Bin Xia, Yu-Ting Lin, Jin-Jian Guo · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.